Cargando…

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer

BACKGROUND: Glutamine serves as an important nutrient with many cancer types displaying glutamine dependence. Following cellular uptake glutamine is converted to glutamate in a reaction catalysed by mitochondrial glutaminase. This glutamate has many uses, including acting as an anaplerotic substrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singleton, Dean C., Dechaume, Anne-Lise, Murray, Pamela M., Katt, William P., Baguley, Bruce C., Leung, Euphemia Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333265/ https://www.ncbi.nlm.nih.gov/pubmed/32450839 http://dx.doi.org/10.1186/s12885-020-06885-3

Ejemplares similares

Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
por: Muir, Alexander, et al.
Publicado: (2017)

Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism
por: Perry, Rachel J., et al.
Publicado: (2016)

Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells
por: Rattigan, Kevin M., et al.
Publicado: (2023)

Elevated Brain Glutamate Levels in Bipolar Disorder and Pyruvate Carboxylase-Mediated Anaplerosis
por: Shen, Jun, et al.
Publicado: (2021)

Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population
por: Leung, Euphemia, et al.
Publicado: (2014)

Targeting Endothelial Cell Metabolism by Inhibition of Pyruvate Dehydrogenase Kinase and Glutaminase-1
por: Schoonjans, Céline A., et al.
Publicado: (2020)

Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies
por: Nguyen, Thuy-Tien T, et al.
Publicado: (2023)

Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer
por: Kitayama, Kishu, et al.
Publicado: (2017)

Replication of the Shrimp Virus WSSV Depends on Glutamate-Driven Anaplerosis
por: Li, Chun-Yuan, et al.
Publicado: (2016)

Hyperoxia induces glutamine-fuelled anaplerosis in retinal Müller cells
por: Singh, Charandeep, et al.
Publicado: (2020)

Inhibition of Anaplerosis Attenuated Vascular Proliferation in Pulmonary Arterial Hypertension
por: Valuparampil Varghese, Mathews, et al.
Publicado: (2020)

Basigin deficiency prevents anaplerosis and ameliorates insulin resistance and hepatosteatosis
por: Ryuge, Akihiro, et al.
Publicado: (2021)

In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
por: Khurshed, Mohammed, et al.
Publicado: (2017)

Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines
por: Kim, Ji Eun, et al.
Publicado: (2013)

Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
por: Martins, Filipa, et al.
Publicado: (2020)

Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells
por: Sant’Anna-Silva, Ana Carolina B., et al.
Publicado: (2021)

Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma
por: Khadka, Sunada, et al.
Publicado: (2021)

In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
por: Cheng, Gary J., et al.
Publicado: (2022)

Simultaneously Targeting Tissue Transglutaminase and Kidney Type Glutaminase Sensitizes Cancer Cells to Acid Toxicity and Offers New Opportunities for Therapeutic Intervention
por: Katt, William P., et al.
Publicado: (2014)

Glucose-dependent anaplerosis in cancer cells is required for cellular redox balance in the absence of glutamine
por: Cetinbas, Naniye Mallı, et al.
Publicado: (2016)

The Role of TCA Cycle Anaplerosis in Ketosis and Fatty Liver in Periparturient Dairy Cows
por: White, Heather M.
Publicado: (2015)

Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition
por: Jeong, Seung Min, et al.
Publicado: (2016)

Mesenchymal stromal cells cultured in physiological conditions sustain citrate secretion with glutamate anaplerosis
por: Taurino, Giuseppe, et al.
Publicado: (2022)

Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages
por: Feng, Yifan, et al.
Publicado: (2022)

Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019)

Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer
por: Hansji, Herah, et al.
Publicado: (2014)

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
por: Leung, Euphemia Y., et al.
Publicado: (2015)

Epigenetic regulation in human melanoma: past and future
por: Sarkar, Debina, et al.
Publicado: (2015)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells
por: Leung, Euphemia, et al.
Publicado: (2011)

Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion
por: Stark, Romana, et al.
Publicado: (2009)

Oligodendroglioma Cells Lack Glutamine Synthetase and Are Auxotrophic for Glutamine, but Do not Depend on Glutamine Anaplerosis for Growth
por: Chiu, Martina, et al.
Publicado: (2018)

Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations
por: Leung, Euphemia Y., et al.
Publicado: (2018)

Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition
por: Lampa, Michael, et al.
Publicado: (2017)

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
por: Ju, YoungJun, et al.
Publicado: (2021)

The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016)

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer
por: Lukey, Michael J., et al.
Publicado: (2019)

Q-ing tumor glutaminase therapy
por: Stine, Zachary E., et al.
Publicado: (2015)

Governing glutaminolysis by regulation of glutaminase succinylation
por: Ma, Qingxia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3jmgmv0131bmsfsufptgoshhjd